I

Immunovant

D
IMVT
USD
-1.47
(-4.6785%)
Market Closed
27,736.00
حجم التداول
-1.402
الربح لكل سهم
-
العائد الربحي
-15.900524
P/E
4,383,702,851.30
حجم السوق
اليوم
-4.6785%
1 اسبوع
2.393%
1 شهر
1.784%
6 اشهر
1.285%
12 اشهر
-13.339%
بداية السنة
-28.911%
كل الوقت
0%

Title:
Immunovant

Sector:
Healthcare
Industry:
Biotechnology
Immunovant Inc is a clinical-stage biopharmaceutical company. It is focused on enabling normal lives for patients with autoimmune diseases. The company's product includes batoclimab and IMVT-1402 targets the neonatal Fc receptor (FcRn).
هل تحتاج مساعدة او لديك استفسار؟